Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Gottlieb

Showing results (501-510 of 523) with videos related to

Pageof 53
Sort By:
Pediatric Dermatology|September 11, 2013
Prevalence of the metabolic syndrome in children with psoriatic diseaseAri M Goldminz, Catherine D Buzney, Noori Kim, et al.
Journal of Drugs in Dermatology : JDD|December 5, 2023
International Dermatology Outcome Measures (IDEOM) - Report from the 2022 Annual MeetingKathryn Lee, Michael J Woodbury, Melissa Peri Zundell, et al.
The Journal of Rheumatology|May 5, 2007
Consensus on a core set of domains for psoriatic arthritisDafna D Gladman, Philip J Mease, Vibeke Strand, et al.
The Journal of Rheumatology|May 3, 2017
Proceedings of the GRAPPA 2016 RetreatDeepak R Jadon, Dafna D Gladman, Philip J Mease, et al.
Human Mutation|December 25, 2007
Recommendations for locus-specific databases and their curationR G H Cotton, A D Auerbach, J S Beckmann, et al.
Therapeutic Advances in Musculoskeletal Disease|January 6, 2022
Axial Involvement in Psoriatic Arthritis cohort (AXIS): the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)Denis Poddubnyy, Xenofon Baraliakos, Filip Van den Bosch, et al.
The New England Journal of Medicine|August 13, 2016
Two Phase 3 Trials of Adalimumab for Hidradenitis SuppurativaAlexa B Kimball, Martin M Okun, David A Williams, et al.
Dermatology and Therapy|December 23, 2018
Clinical Goals and Barriers to Effective Psoriasis CareBruce E Strober, Joelle M van der Walt, April W Armstrong, et al.
Journal of Drugs in Dermatology : JDD|December 2, 2025
Report From the 2024 International Dermatology Outcome Measures (IDEOM) Annual MeetingSarah Romanelli, Gretchen D Ball, Arianna J Zhang, et al.
Journal of the American Academy of Dermatology|February 28, 2004
A systemic type I 5 alpha-reductase inhibitor is ineffective in the treatment of acne vulgarisJames Leyden, Wilma Bergfeld, Lynn Drake, et al.
Pageof 53

Showing results (501-510 of 523) with videos related to

Sort By:
Pageof 53
Pediatric Dermatology|September 11, 2013
Prevalence of the metabolic syndrome in children with psoriatic diseaseAri M Goldminz, Catherine D Buzney, Noori Kim, et al.
Journal of Drugs in Dermatology : JDD|December 5, 2023
International Dermatology Outcome Measures (IDEOM) - Report from the 2022 Annual MeetingKathryn Lee, Michael J Woodbury, Melissa Peri Zundell, et al.
The Journal of Rheumatology|May 5, 2007
Consensus on a core set of domains for psoriatic arthritisDafna D Gladman, Philip J Mease, Vibeke Strand, et al.
The Journal of Rheumatology|May 3, 2017
Proceedings of the GRAPPA 2016 RetreatDeepak R Jadon, Dafna D Gladman, Philip J Mease, et al.
Human Mutation|December 25, 2007
Recommendations for locus-specific databases and their curationR G H Cotton, A D Auerbach, J S Beckmann, et al.
Therapeutic Advances in Musculoskeletal Disease|January 6, 2022
Axial Involvement in Psoriatic Arthritis cohort (AXIS): the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)Denis Poddubnyy, Xenofon Baraliakos, Filip Van den Bosch, et al.
The New England Journal of Medicine|August 13, 2016
Two Phase 3 Trials of Adalimumab for Hidradenitis SuppurativaAlexa B Kimball, Martin M Okun, David A Williams, et al.
Dermatology and Therapy|December 23, 2018
Clinical Goals and Barriers to Effective Psoriasis CareBruce E Strober, Joelle M van der Walt, April W Armstrong, et al.
Journal of Drugs in Dermatology : JDD|December 2, 2025
Report From the 2024 International Dermatology Outcome Measures (IDEOM) Annual MeetingSarah Romanelli, Gretchen D Ball, Arianna J Zhang, et al.
Journal of the American Academy of Dermatology|February 28, 2004
A systemic type I 5 alpha-reductase inhibitor is ineffective in the treatment of acne vulgarisJames Leyden, Wilma Bergfeld, Lynn Drake, et al.
Pageof 53